Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer

Journal article

Irshad S. et al, (2017), The Journal of Pathology, 242, 178 - 192

Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer

Journal article

Irshad S. et al, (2017), JOURNAL OF PATHOLOGY, 242, 178 - 192

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Journal article

Shimelis H. et al, (2017), Cancer Res, 77, 2789 - 2799

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Journal article

Muranen TA. et al, (2017), Genet Med, 19, 599 - 603

BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer.

Journal article

López-García C. et al, (2017), Cancer Cell, 31, 79 - 93

Cancer predisposition syndromes: lessons for truly precision medicine.

Journal article

Glaire MA. et al, (2017), J Pathol, 241, 226 - 235

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

Journal article

Southey MC. et al, (2016), J Med Genet, 53, 800 - 811

Clinical manifestations of colorectal cancer patients from a large multicenter study in Colombia.

Journal article

Bohorquez M. et al, (2016), Medicine (Baltimore), 95

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.

Journal article

Gharahkhani P. et al, (2016), Lancet Oncol, 17, 1363 - 1373

Load More